Bumper Offer - Urjas oil Just @ Rs. 1
Ciclesonide + Formoterol + Tiotropium is an allopathic medicine The correct dosage of Ciclesonide + Formoterol + Tiotropium depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Ciclesonide + Formoterol + Tiotropium is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Ciclesonide + Formoterol + Tiotropium is used -
Severe
Moderate
Mild
Common
Unknown
Is the use of Ciclesonide + Formoterol + Tiotropium safe for pregnant women?
Pregnant women may experience moderate side effects from Ciclesonide + Formoterol + Tiotropium. It is best to stop taking Ciclesonide + Formoterol + Tiotropium immediately and inform your doctor if you notice any discomfort.
Is the use of Ciclesonide + Formoterol + Tiotropium safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Ciclesonide + Formoterol + Tiotropium for breastfeeding women are not known.
What is the effect of Ciclesonide + Formoterol + Tiotropium on the Kidneys?
Ciclesonide + Formoterol + Tiotropium rarely harms the kidneys.
What is the effect of Ciclesonide + Formoterol + Tiotropium on the Liver?
There may be an adverse effect on the liver after taking Ciclesonide + Formoterol + Tiotropium. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Ciclesonide + Formoterol + Tiotropium on the Heart?
Ciclesonide + Formoterol + Tiotropium can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
Ciclesonide + Formoterol + Tiotropium should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Ciclesonide + Formoterol + Tiotropium unless your doctor advises you to do so -
Is this Ciclesonide + Formoterol + Tiotropium habit forming or addictive?
Forming a habit of Ciclesonide + Formoterol + Tiotropium has not been reported.
Interaction between Food and Ciclesonide + Formoterol + Tiotropium
Due to a lack of research, nothing can be said about the consequences of taking Ciclesonide + Formoterol + Tiotropium together with food.
Interaction between Alcohol and Ciclesonide + Formoterol + Tiotropium
Information about the interaction of Ciclesonide + Formoterol + Tiotropium and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Alvesco® (ciclesonide)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 359-360
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1207
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 117
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Spiriva® HandiHaler® (tiotropium bromide)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Braltus® (tiotropium bromide)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Perforomist® (formoterol fumarate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 595-596
